ZA984633B - Treatment of schizophrenia and psychosis - Google Patents
Treatment of schizophrenia and psychosisInfo
- Publication number
- ZA984633B ZA984633B ZA984633A ZA984633A ZA984633B ZA 984633 B ZA984633 B ZA 984633B ZA 984633 A ZA984633 A ZA 984633A ZA 984633 A ZA984633 A ZA 984633A ZA 984633 B ZA984633 B ZA 984633B
- Authority
- ZA
- South Africa
- Prior art keywords
- psychosis
- schizophrenia
- treatment
- diseases
- methylpyridine
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- RNMOMKCRCIRYCZ-UHFFFAOYSA-N Alvameline Chemical compound CCN1N=NC(C=2CN(C)CCC=2)=N1 RNMOMKCRCIRYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000020186 Schizophreniform disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK62097 | 1997-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA984633B true ZA984633B (en) | 1998-12-11 |
Family
ID=8095640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA984633A ZA984633B (en) | 1997-05-29 | 1998-05-29 | Treatment of schizophrenia and psychosis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6297262B1 (OSRAM) |
| EP (1) | EP1014974B1 (OSRAM) |
| JP (1) | JP2002500651A (OSRAM) |
| AT (1) | ATE273007T1 (OSRAM) |
| AU (1) | AU7639598A (OSRAM) |
| DE (1) | DE69825605T2 (OSRAM) |
| ES (1) | ES2227836T3 (OSRAM) |
| PT (1) | PT1014974E (OSRAM) |
| WO (1) | WO1998053820A1 (OSRAM) |
| ZA (1) | ZA984633B (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091357B2 (en) * | 2001-12-26 | 2006-08-15 | University Of Kentucky Research Foundation | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
| DK1766077T3 (da) | 2004-06-21 | 2012-07-16 | Univ Leland Stanford Junior | Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| EP1951908B1 (en) | 2005-11-12 | 2013-08-07 | The Board of Trustees of The Leland Stanford Junior University | Fgf2-related methods for diagnosing and treating depression |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| CA2875674A1 (en) | 2012-06-05 | 2013-12-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics |
| WO2017147104A1 (en) * | 2016-02-24 | 2017-08-31 | Chase Pharmaceuticals Corporation | Muscarinic m2-antagonist combinations |
| WO2018039159A1 (en) * | 2016-08-22 | 2018-03-01 | Chase Pharmaceuticals Corporation | Muscarinic m2-antagonist combination |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE845612A (fr) | 1976-03-23 | 1977-02-28 | Derives de tetrazole-5-carboxamide et leur preparation | |
| DE3421072A1 (de) | 1984-06-06 | 1985-12-12 | Heinrich Mack Nachf., 7918 Illertissen | 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| EP0261763B1 (en) | 1986-06-27 | 1994-02-09 | Beecham Group Plc | Novel bridged bicyclic N-heterocycles |
| IL83275A (en) | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them |
| GB8714789D0 (en) | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| GB8717446D0 (en) | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| US5405853A (en) | 1987-09-10 | 1995-04-11 | Merck Sharpe & Dohme Ltd. | Thiadiazoles useful in the treatment of senile dementia |
| US5328925A (en) | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
| US5043345A (en) | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
| IE922270A1 (en) | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
| US5330994A (en) | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
| AU674541B2 (en) | 1992-08-31 | 1997-01-02 | University Of Florida Research Foundation, Inc. | Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| CZ181493A3 (en) | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
| DK0734259T3 (da) | 1993-08-19 | 2002-09-30 | Novo Nordisk As | Antipsykotisk fremgangsmåde |
| US5705512A (en) | 1994-11-10 | 1998-01-06 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
| US5585388A (en) | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5691365A (en) | 1995-07-18 | 1997-11-25 | University Of Kentucky Research Foundation | Nicotinic receptor antagonists in the treatment of neuropharmacological disorders |
| US5756501A (en) | 1995-12-13 | 1998-05-26 | American Home Products Corporation | Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents |
| US5739119A (en) | 1996-11-15 | 1998-04-14 | Galli; Rachel L. | Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
-
1998
- 1998-05-28 WO PCT/DK1998/000220 patent/WO1998053820A1/en not_active Ceased
- 1998-05-28 PT PT98924064T patent/PT1014974E/pt unknown
- 1998-05-28 DE DE69825605T patent/DE69825605T2/de not_active Expired - Fee Related
- 1998-05-28 US US09/424,822 patent/US6297262B1/en not_active Expired - Fee Related
- 1998-05-28 JP JP50012799A patent/JP2002500651A/ja not_active Ceased
- 1998-05-28 ES ES98924064T patent/ES2227836T3/es not_active Expired - Lifetime
- 1998-05-28 AT AT98924064T patent/ATE273007T1/de not_active IP Right Cessation
- 1998-05-28 EP EP98924064A patent/EP1014974B1/en not_active Expired - Lifetime
- 1998-05-28 AU AU76395/98A patent/AU7639598A/en not_active Abandoned
- 1998-05-29 ZA ZA984633A patent/ZA984633B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1014974E (pt) | 2004-12-31 |
| EP1014974A1 (en) | 2000-07-05 |
| EP1014974B1 (en) | 2004-08-11 |
| AU7639598A (en) | 1998-12-30 |
| DE69825605T2 (de) | 2005-09-15 |
| ES2227836T3 (es) | 2005-04-01 |
| DE69825605D1 (de) | 2004-09-16 |
| JP2002500651A (ja) | 2002-01-08 |
| US6297262B1 (en) | 2001-10-02 |
| ATE273007T1 (de) | 2004-08-15 |
| WO1998053820A1 (en) | 1998-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7639598A (en) | Treatment of schizophrenia and psychosis | |
| TW249226B (OSRAM) | ||
| NO900439L (no) | Fremgangsmaate for behandling av uorganisk pulver. | |
| NO913765D0 (no) | Fremgangsmaate for kontinuerlig fremstilling av tyggegummi. | |
| NO911934D0 (no) | Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner. | |
| FI913017A7 (fi) | Menetelmä antianginaalisten 5-(2-alkoksi-5-piperidinyyli- ja -piperatsinyylisulfonyylifenyyli)-1,6-dihydro-7H-pyratsolo/4,3-d/pyrimidin-7-onien valmistamiseksi ja välituotteita | |
| AU6801694A (en) | The treatment of small animals | |
| NO944871D0 (no) | Fremgangsmåte for fremstilling av polydimetylsiloksaner | |
| NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
| EP0467564A3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
| FI941776A0 (fi) | Menetelmä 1,2,4-tiadiatsolien valmistamiseksi | |
| AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
| AU3187595A (en) | Compounds for the treatment of restenosis | |
| EP0424156A3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
| NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| AU4712696A (en) | The use of heterocyclic compounds | |
| ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
| AU4081393A (en) | Medicaments for the treatment of anxiety | |
| ITRM950484A0 (it) | Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla gastrica e quindi gastroprotettivo. | |
| AU639322B2 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
| NO931839L (no) | Fremgangsm}te for fremstilling av pergolid | |
| SI0778025T1 (en) | Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals | |
| AU5018893A (en) | Substituted hydrindanes for the treatment of angiogenesis-dependent diseases | |
| IT1296613B1 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
| IL117465A (en) | Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis |